FIG. 1.
(A) Raltegravir concentrations in plasma and semen samples obtained from 10 HIV-infected patients enrolled in the EASIER-ANRS 138 trial at week 24, 5 hours following drug intake. Semen (grey bars) and plasma (black bars) samples were drawn at 5 h postdosing. A plasma sample from patient 8 was drawn at 9 h postdosing (hatched bars). (B) Individual semen-to-plasma ratios of raltegravir concentrations. The ratio is not calculated for patient 8.